ArticleFrontiers in oncology2020

Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma.

Jian-Zhao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.